A
Arun Satelli
Researcher at University of Texas MD Anderson Cancer Center
Publications - 24
Citations - 2499
Arun Satelli is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 15, co-authored 22 publications receiving 2045 citations. Previous affiliations of Arun Satelli include University of Texas System & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Vimentin in cancer and its potential as a molecular target for cancer therapy.
Arun Satelli,Shulin Li +1 more
TL;DR: By virtue of its overexpression in cancer and its association with tumor growth and metastasis, vimentin serves as an attractive potential target for cancer therapy; however, more research would be crucial to evaluate its specific role in cancer.
Journal ArticleDOI
Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli,Abhisek Mitra,Zachary Brownlee,Xueqing Xia,Seth Bellister,Michael J. Overman,Scott Kopetz,Lee M. Ellis,Qing H. Meng,Shulin Li,Shulin Li +10 more
TL;DR: These results establish CSV as a universal marker for EMT CTCs from a wide variety of tumor types and thus provide the foundation for emerging CTC detection technologies and for studying the molecular regulation of these EMTCs.
Journal ArticleDOI
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
Arun Satelli,Izhar Singh Batth,Zachary Brownlee,Christina R. Rojas,Qing H. Meng,Scott Kopetz,Shulin Li,Shulin Li +7 more
TL;DR: It is suggested that use of CTC-based models of cancer for risk assessment can improve the standard cancer staging criteria and supported the incorporation of nPD-L1 expression detection in CTCs detection in such models.
Journal ArticleDOI
Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule– and Cell-Surface Vimentin–Based Methods for Monitoring Breast Cancer Therapeutic Response
TL;DR: The sum of CTC counts from the CellSearch and CSV methods appears to provide new insights for assessment of therapeutic response and thus provides a new approach to personalized medicine in breast cancer patients.
Journal ArticleDOI
Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells
Arun Satelli,Abhisek Mitra,Jeffry Cutrera,Marcos Devarie,Xueqing Xia,Davis R. Ingram,Denada Dibra,Neeta Somaiah,Keila E. Torres,Vinod Ravi,Joseph A. Ludwig,Eugenie S. Kleinerman,Shulin Li +12 more
TL;DR: The results establish the first universal and specific CTC marker described for enumerating CTCs from different types of sarcoma, thereby providing a key prognosis tool to monitor cancer metastasis and relapse.